Anne Ørbo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anne Ørbo has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
André Slappendel
Medical Center Alkmaar, Wilhelminalaan 12, 1815 JD Alkmaar, The Netherlands
1 shared publicationB Straume
Institute of Community Medicine, Faculty of Medicine, University of Tromsø, Tromsø, Norway
1 shared publicationHans J Tichelaar
Medical Center Alkmaar, Wilhelminalaan 12, 1815 JD Alkmaar, The Netherlands
1 shared publicationInger Kleivan
Institute of Medical Biology, University of Tromsø, N-9037 Tromsø, Norway
1 shared publication- Jan P A Baak
Department of Pathology, Academic Hospital, Free University, de Bokelaan 1117, 108 1HV Amsterdam, The Netherlands
1 shared publication M Rydningen
Department of Pathology, University hospital of Tromsø, Institute for Medical Biology, and
1 shared publication
Latest Publications
- 1 January 2002
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 12 (1) , 49-56
Significance of morphometric, DNA cytometric features, and other prognostic markers on survival of endometrial cancer patients in northern Norway
- 1 January 2002
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 12 (1) , 49-56
Significance of morphometric, DNA cytometric features, and other prognostic markers on survival of endometrial cancer patients in northern Norway
- Open Access
- 1 September 2000
- Published by BMJ in Journal of Clinical Pathology
- Vol. 53 (9) , 697-703
Computerised morphometrical analysis in endometrial hyperplasia for the prediction of cancer development. A long term retrospective study from northern Norway
Aims— To evaluate and compare the long term prognostic value of the WHO classification and the computerised multivariate morphometrical D score in endometrial hyperplasia. To test the reproducibility of the D score in two different centres. Methods— Histopathological WHO classification and computerised morphometrical analysis using the D score (< 0, high risk; > 1, low risk; 0–1, uncertain) in a population based study from northern Norway of archival dilatation and curettage material from 68 women with 10–20 years of follow up. Results —Of the 68 patients included in the study, 18 developed cancer. The sensitivity and specificity of the D score (< 0 v > 1) were 100% and 78%, respectively, which was better than the WHO classification (89% and 60%, respectively). The negative and positive predictive values for the D score were 100% and 58% and of the WHO classification 94% and 44%, respectively. This study found a slightly higher specificity for the D score than former retrospective studies, but otherwise the results were comparable. The D score results were reproducible between the two centres (R = 0.91; slope = 0.98; intercept = 0.3). Conclusions —D score assessment is a reproducible and more accurate predictor of outcome of endometrial hyperplasia than the WHO classification assessed by an experienced gynaecological pathologist. Routine application of the D score might reduce over and undertreatment of endometrial hyperplasia.
- 1 September 2000
- Published by BMJ in Journal of Clinical Pathology
- Vol. 53 (9) , 697-703
Open AccessComputerised morphometrical analysis in endometrial hyperplasia for the prediction of cancer development. A long term retrospective study from northern Norway
Aims— To evaluate and compare the long term prognostic value of the WHO classification and the computerised multivariate morphometrical D score in endometrial hyperplasia. To test the reproducibility of the D score in two different centres. Methods— Histopathological WHO classification and computerised morphometrical analysis using the D score (< 0, high risk; > 1, low risk; 0–1, uncertain) in a population based study from northern Norway of archival dilatation and curettage material from 68 women with 10–20 years of follow up. Results —Of the 68 patients included in the study, 18 developed cancer. The sensitivity and specificity of the D score (< 0 v > 1) were 100% and 78%, respectively, which was better than the WHO classification (89% and 60%, respectively). The negative and positive predictive values for the D score were 100% and 58% and of the WHO classification 94% and 44%, respectively. This study found a slightly higher specificity for the D score than former retrospective studies, but otherwise the results were comparable. The D score results were reproducible between the two centres (R = 0.91; slope = 0.98; intercept = 0.3). Conclusions —D score assessment is a reproducible and more accurate predictor of outcome of endometrial hyperplasia than the WHO classification assessed by an experienced gynaecological pathologist. Routine application of the D score might reduce over and undertreatment of endometrial hyperplasia.